Mathias Oelke - 04 Apr 2023 Form 4 Insider Report for NexImmune, Inc.

Role
Chief Science Officer
Signature
/s/ John Rudy, attorney-in-fact
Issuer symbol
NEXI on OTC
Transactions as of
04 Apr 2023
Net transactions value
$0
Form type
4
Filing time
06 Apr 2023, 20:41:52 UTC
Previous filing
25 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEXI Stock Option (right to buy) Award $0 +81,100 $0.000000 81,100 04 Apr 2023 Common Stock 81,100 $0.4100 Direct F1
transaction NEXI Stock Option (right to buy) Disposed to Issuer -60,000 -100% 0 04 Apr 2023 Common Stock 60,000 $4.22 Direct F2
transaction NEXI Stock Option (right to buy) Award +21,250 21,250 04 Apr 2023 Common Stock 21,250 $1.23 Direct F2
transaction NEXI Stock Option (right to buy) Award +38,750 38,750 04 Apr 2023 Common Stock 38,750 $0.8200 Direct F2
transaction NEXI Stock Option (right to buy) Disposed to Issuer -19,905 -100% 0 04 Apr 2023 Common Stock 19,905 $17.00 Direct F3
transaction NEXI Stock Option (right to buy) Award +12,855 12,855 04 Apr 2023 Common Stock 12,855 $1.23 Direct F3
transaction NEXI Stock Option (right to buy) Award +7,050 7,050 04 Apr 2023 Common Stock 7,050 $0.8200 Direct F3
transaction NEXI Stock Option (right to buy) Disposed to Issuer -31,948 -100% 0 04 Apr 2023 Common Stock 31,948 $4.31 Direct F4
transaction NEXI Stock Option (right to buy) Award +31,948 31,948 04 Apr 2023 Common Stock 31,948 $1.23 Direct F4
transaction NEXI Stock Option (right to buy) Disposed to Issuer -4,755 -100% 0 04 Apr 2023 Common Stock 4,755 $2.58 Direct F5
transaction NEXI Stock Option (right to buy) Award +4,755 4,755 04 Apr 2023 Common Stock 4,755 $1.23 Direct F5
transaction NEXI Stock Option (right to buy) Disposed to Issuer -115,051 -100% 0 04 Apr 2023 Common Stock 115,051 $2.58 Direct F6
transaction NEXI Stock Option (right to buy) Award +115,051 115,051 04 Apr 2023 Common Stock 115,051 $1.23 Direct F6
transaction NEXI Stock Option (right to buy) Disposed to Issuer -47,379 -100% 0 04 Apr 2023 Common Stock 47,379 $2.42 Direct F7
transaction NEXI Stock Option (right to buy) Award +47,379 47,379 04 Apr 2023 Common Stock 47,379 $1.23 Direct F7
transaction NEXI Stock Option (right to buy) Disposed to Issuer -15,793 -100% 0 04 Apr 2023 Common Stock 15,793 $2.42 Direct F7
transaction NEXI Stock Option (right to buy) Award +15,793 15,793 04 Apr 2023 Common Stock 15,793 $1.23 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on April 4, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Oelke's continued service to the corporation on each vesting date.
F2 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on April 5, 2022, of which 15,000 shares vested, and the remainder of the options will vest in equal monthly installments such that on May 5, 2025, all shares subject to the option shall be vested, subject to Mr. Oelke's continued service on each vesting date.
F3 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which 10,367 shares vested, and the remainder of the options will vest in equal monthly installments such that on February 11, 2025, all shares subject to the option shall be vested, subject to Mr. Oelke's continued service on each vesting date.
F4 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 19, 2019, of which all of the shares subject to such option have vested.
F5 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on September 25, 2018, of which all of the shares subject to such option have vested.
F6 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on July 31, 2021, of which all of the shares subject to such option have vested.
F7 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 3, 2017, of which all of the shares subject to such option have vested.